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Background: A heterogeneous platelet reactivity
response to clopidogrel exists, and the clinical or bio-
chemical predictors of suboptimal response to clopido-
grel remain unclear.
Objectives: The goal of this study was to identify fac-
tors associated with higher platelet aggregation following
clopidogrel therapy in subjects with acute coronary syn-
drome (ACS).
Methods: This study was conducted on 62 subjects
with ACS requiring treatment with clopidogrel (75 mg
daily for 7 days or more). The subjects were divided into
diabetic and non diabetic groups. Chrono-log Aggergom-
eter Series 490 used to estimate platelet aggregation. Fac-
tors associated with lower response to clopidogrel were
identified.
Results: A heterogeneous, normally distributed
platelet aggregation (mean 38.58 ± 18.6%) was observed
in 62 subjects (age 56.13 ± 7.9 years; 66.1% men). Statisti-
cal analysis revealed significant increased platelet aggre-
gation in patients with history of coronary artery disease
(CAD) (44.17 ± 16.3 vs 31.33 ± 19.17, p = 0.006), hyperten-
sion (44.47 ± 18.79 vs 31.43 ± 15.91, p = 0.005) and body
mass index (BMI) P 5 kg/m2 (42.54 ± 17.6 vs
27.19 ± 17.04, p = 0.004). Diabetic patients demonstrated
a trend to lower response to clopidogrel treatment with
platelet aggregation (42.87 ± 18.54) compared to non dia-
betic patients (34.29 ± 17.93) but this did not reach a sta-
tistical significance (p = 0.069). Positive correlations were
found between platelet aggregation % and the level of
fasting blood sugar (P < 0.001), body weight (p = 0.023)
and BMI (P = 0.005).
Conclusions: Hypertension, past history of CAD,
BMIP25 kg/m2 and diabetes mellitus are associated with
higher platelet aggregation following clopidogrel treat-
ment in patients with ACS. Positive correlations were
found between platelet aggregation and the level of fast-
ing blood sugar, body weight and BMI in those patients.
http://dx.doi:10.1016/j.jsha.2013.03.086
Obesity in Egyptian children: Effect on cardiac
function and dimensions
Inas A. Saad, Tarek S. Ibrahim
Objectives: To define the effect of obesity in Egyp-
tian children on cardiac function and dimensions also
to investigate the possible relation between obesity and
other co-morbid cardiovascular risk factors.
Methods: Prospective descriptive study conducted
over 15 months and included 44 children with xogenous
obesity aged from 4 to 16 years with a mean of
8.54 ± 2.4 years in addition to a healthy normal weight,
matched age and sex 35 children as a control group. All
study groups underwent clinical examination, lipid pro-
file in addition to meticulous echocardiography study.
Results: Blood pressure was comparable in both
groups and mean serum triglyceride level (though in
the normal range) was significantly higher in the obese
group with P = 0.035. left ventricular wall thickness, mass
and mass index were significantly higher in obese group
compared to normal weight group with P value 0.001,
0.045 and 0.035 respectively. Myocardial diastolic func-
tion presented by isovolumetric relaxation time and E/
A was significantly different in favor for the control
group. However by correlating cardiac dimension with
the lipid profile no significant relation could be elicited.
Conclusions: Obesity in the absence of dyslipidemia
and hypertension (as co-morbid cardiovascular risk fac-
tors) is associated with increased left ventricular wall
thickness and mass also it is a risk factor for left ventricle
diastolic dysfunction.
http://dx.doi:10.1016/j.jsha.2013.03.087
The fate of the neoaortic valve and root following
the modified Ross-Konno
I. Al Abri, Z. Al-Halees, M. Al-Fayyadh,
Z. Al-Bulbul, M. Al-Ahmadi, B. Alsoufi
Objectives: In children with aortic valve disease
associated with annular hypoplasia or complex multi-
level left ventricular outflow tract obstruction (LVOTO),
the Ross procedure, combined with a modified Konno-
type aortoventriculoplasty is advocated. We aim to
examine the fate of the neoaortic apparatus and assess
neoaortic valve function following the modified Ross-
Konno procedure.
Methods: Forty-three patients, median age 6 years,
underwent modified Ross- Konno with myectomy but
without ventricular septal patch utilization. Serial post-
operative echocardiograms (n = 187) were analyzed and
regression models adjusted for repeated measures were
used to model longitudinal growth of neoaortic annulus
and root.
Results: There were 2 operative deaths (5%) and 1
late mortality. At 8 years, survival was 93% and freedom
from autograft, homograft and all-cause reoperation was
100%, 81%, and 72%, respectively. Median post-proce-
dure diameter and Z-score were 14 mm (7–21 mm), and
1.25 (3 to +6.1) for neoaortic annulus and 21 mm (9–
30 mm) and 1.55 (1.3 to +4.1) for neoaortic root. Serial
echocardiograms showed progressive increase in annular
(+0.56 mm/year, p < 0.001) and root (+0.89 mm/year,
p < 0.001) diameters but little change in annular (0.07/
year, p = 0.08) and root (0.002/year, p = 0.96) Z-scores.
Nine patients developed autograft regurgitation, how-
ever the degree and progression of regurgitation were
not significant (p = 0.22).
Conclusions: In children undergoing the modified
Ross-Konno procedure, the neoaortic annulus and root
increase in size proportionately to somatic growth. Few
patients developed autograft regurgitation, usually mild
and stable, and none required autograft reoperation.
Our findings support the use of modified Ross-Konno
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as the procedure of choice in children with aortic valve
disease and complex LVOTO.
http://dx.doi:10.1016/j.jsha.2013.03.088
Impact of optimal medical therapy (OMT), versus
optimal medical therapy plus revascularizations
(OMTR) on allcause mortality, in patients with
IHD
Iyad Farah, Tara Conboy, M. Bassam Bdeir
Background: Currently, there is no significant differ-
ence between OMT versus OMTR on all-cause mortality
in patients with IHD. There is no data in this region.
Objectives: Evaluate the impact of OMT versus
OMTR on primary end point of allcause mortality in
patients with IHD.
Method: Data was collected, retrospectively, from
the electronic database for all patients with IHD
(n = 2,692) attending Cardiovascular Disease Manage-
ment Program (CVDMP), KAMC-Riyadh, between April
2000 and October 2011. Patients with no follow-up visits
(n = 59), or had non obstructive CAD (n = 280) were
excluded. OMT is an integral component of routine care
within CVDMP. Data was analyzed using SPSS.
Results: Mean age was 60 ± 10 years, 22% were
female, and average follow-up was 40 ± 33 months. Base-
line characteristics were similar for both groups with
exception of LVEF which was 38% versus 46% (p < 0.001),
and documented heart failure (HF) 60% versus 31%
(p < 0.001), respectively in OMT and OMTR. Of the
enrolled patients (n = 2353), 86% (n = 2031) underwent
revascularization, while 14% (n = 322) remained on OMT
for the following reasons; 18% (n = 59) refused interven-
tion and 82% (n = 263) were declined intervention by the
treating team. All-cause mortality was 3.3% (n = 87) in
the total population; 2.2% (45/2031) in the OMTR group
versus 11% (35/322) in the OMT group (P < 0.0001).
Conclusion: Mortality was higher in OMT group,
which had a higher prevalence of HF and lower baseline
LVEF.
http://dx.doi:10.1016/j.jsha.2013.03.089
IV Paracetamol as a sole agent for postoperative
pain relief in adult cardiac surgical patients after
median sternotomy
Jamshid Ali Mullah, Khaled Farouk, Mutasim
Hammad
1&3 Consultant Cardiac Anesthesia, 2 Consultant CCM,
PSCCQ, Saudi Arabia
Introduction: Various pain control strategies for pain
relief of cardiac surgical patients after median sternotomy
were tried include central neuraxial blockade or selective
nerve blocks, anddrugs such as opioids, andnon-steroidal
anti-inflammatory drugs (NSAIDS). Paracetamol (Perfal-
gan, Bristol Meyers Squibb) is available in IV formulation
and is being used inmany centers as an adjunct to analge-
sia regimen. In our practice, we have found that IV para-
cetamol stared at regular intervals after shifting the
patient to cardiac surgical ICU(CSICU), helps in signifi-
cantly reducing the analgesic requirement consequently
patients become less sedated after cardiac surgery.
Methods: After ethics committee approval, and
informed patient consent, we did a prospective cohort
study of 52 adult cardiac surgical receiving IV paracetamol
as the primary pain control agent. A standard anesthesia
andanalgesia techniquewasused for all thepatients. Post-
operatively IV fentanyl infusion was continued at 1 mcg/
kg/h till extubation. IV paracetamol was started 30 min
before extubation given 1 g (over 30 min) IV and continued
6 h till next 72 h or till chest tube removal. Pain control was
assessed by visual analogue scale (VAS) and target VAS
value of 3 or less than three was considered adequate.
VAS was assessed at extubation, at 3, 6, 12, 24, 36 and
48 h after extubation. The regimen was considered suc-
cessful if only two or less than two doses of IV fentanyl
and/or less than 4 doses of oral tramadol were required
to supplement IV paracetamol postoperatively.
Results: The patient age ranged from 24 to 78 years,
8 of them were female, CABG was performed in 14
patients, AVR in 8 patients, CABG plus MVR in 6
patients, CABG plus AVR in 10 patients, MVR plus
RFA in 6 patients, ASD closure in 4 patients and pulmon-
ary valve implantation in 2 patient. We found that para-
cetamol was successful as the sole analgesic agent in 38
patients (73%), in 10 patients (19.2%) IV paracetamol
was primary regimen (with fentanyl/tramadol as adjunct)
and in 4 patients (7.6%) patients IV paracetamol regimen
was unsuccessful in pain relief.
Conclusion: IV Paracatamol may be used as a sole
agent for pain relief with successful results after median
sternotomy in selected patients in which opioids, NSAIDS
or regional blocks are not indicated or produce undesirable
side effects. The results need to be reproduced in a larger
group of patients and after determining equipotent doses
of opiods, case control studies should be done to evaluate
the effects of IV paracetamol after median sternotomy.
http://dx.doi:10.1016/j.jsha.2013.03.090
Clinical and prognostic comparison between Mid-
dle-East and Indian subcontinent patients follow-
ing acute coronary syndrome
Kadhim Sulaiman, Prashanth Panduranga,
Ibrahim Alzakwani, Khalid Al-Habib,
Ahmed Hersi, Jassim Al Suwaidi
Background: Data comparing acute coronary syn-
drome (ACS) patients from the Middle East with those
from the Indian subcontinent is scarce. The aim of this
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